Open AccessCost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy
Author(s) -
Roberto Ravasio,
Giuseppe Nicolò,
Marco Vaggi
Publication year - 2014
Publication title -
global and regional health technology assessment
Language(s) - English
Resource type - Journals
eISSN - 2283-5733
pISSN - 2284-2403
DOI - 10.5301/grhta.5000186
Subject(s) - paliperidone palmitate , risperidone , medicine , discontinuation , paliperidone , cost effectiveness , extrapyramidal symptoms , schizophrenia (object oriented programming) , cost–utility analysis , pediatrics , psychiatry , antipsychotic , risk analysis (engineering)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom